Organization · Venture Capital
XYence Capital SGR
XYence Capital SGR is an independent fund manager based in Milan, Italy, specializing in the life sciences sector, particularly oncology and healthcare. The firm manages two active funds and has made several investments in innovative companies within this field.
Overview
What XYence Capital SGR does
What XYence Capital SGR is
XYence Capital SGR is an independent fund manager based in Milan, Italy, specializing in the life sciences sector, particularly oncology and healthcare. The firm manages two active funds and has made several investments in innovative companies within this field.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find XYence Capital SGR elsewhere
Open the official website or a supported primary organization account.
Capability profile
XYence Capital SGR as a funder
Investment thesis
XYence Capital SGR specializes in investing in Italian life sciences, focusing on oncology and healthcare innovation, while collaborating with academic and clinical entrepreneurs.
Focus narrative
XYence Capital SGR focuses on investments in the life sciences sector, particularly in oncology and healthcare. The firm seeks to identify and support innovative companies that are developing groundbreaking therapies and technologies.
Value beyond capital
XYence Capital SGR adds value to its portfolio companies by leveraging its expertise in life sciences and its network of academic and clinical partners. The firm provides strategic guidance and support to help companies navigate the complexities of the healthcare landscape.
Focus and fit
- Stages
- Seed · Series A · Series B · Growth Equity
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 11
- Recorded notable exits
- CrestOptics and TRIFARMA
Portfolio context
XYence Capital SGR has made notable investments in companies such as Checkmab S.r.l., a developer of novel cancer immunotherapies, and Enterome, which specializes in microbiome therapeutics. Other investments include DoveConviene, a consumer/mobile platform, and CrestOptics, which has been acquired. The firm has successfully exited two investments via acquisition, indicating a strong track record in the life sciences sector.
Common questions
What to know about XYence Capital SGR
Upseed classifies XYence Capital SGR under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.